Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mandalapu, B. P.
Right arrow Articles by Stratmann, H. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mandalapu, B. P.
Right arrow Articles by Stratmann, H. G.
(Chest. 1999;115:1684-1694.)
© 1999 American College of Chest Physicians

Technetium Tc 99m Sestamibi Myocardial Perfusion Imaging*

Current Role for Evaluation of Prognosis

Bhuvana P. Mandalapu , MD; Maryellen Amato , MD and Henry G. Stratmann , MD, FCCP

* From the Department of Cardiology (Drs. Stratmann and Mandalapu) and Department of Nuclear Medicine (Dr. Amato), St. Louis Veterans Administration Medical Center, St. Louis, MO.

Like 201Tl imaging, technetium Tc 99m sestamibi (MIBI) myocardial imaging can be used with exercise and pharmacologic testing to assess the presence of coronary artery disease. An increasing body of literature indicates that MIBI can also be used to assess risk of future cardiac events such as myocardial infarction or death. This article summarizes the current status of MIBI imaging for evaluating prognosis in patients with known or suspected coronary artery disease.

Key Words: coronary disease • dipyridamole • exercise test • prognosis • single-photon emission CT • technetium-99m sestamibi






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.